October 1, 2022

Despite Pressure, Biogen’s Alzheimer’s Drug Still a Likely Blockbuster

American taxpayers are set to foot most of the bill for Biogen ’s new treatment for Alzheimer’s disease, and investors are nervous.

The Food and Drug Administration approved Aduhelm earlier this month despite significant controversy; several prominent experts have blasted regulators for allowing the sale of an ineffective drug.

Those arguments didn’t persuade the FDA, but the spat raises the question over how Medicare will pay for the medication, which carries an annual sticker price of $56,000 before rebates or discounts. Investors are pricing in some doubt that Aduhelm will ever live up its blockbuster expectations: Biogen shares have risen 30% over the past month, but have shed nearly 20% since June 10.

There are good reasons for skepticism. While Medicare typically pays for all approved drugs, a Biden administration official said that the government “can’t afford to treat this as business as usual.” And the price of Aduhelm is merely one line item in a list of necessary expenses for patients receiving it. Others are brain-imaging tests, infusion costs and a parade of doctor visits to assess disease progression.

What is more, Biogen could face competition sooner than Wall Street had expected. Rival drugmaker Eli Lilly said last week it plans to file for regulatory approval for its own Alzheimer’s treatment; that drug could conceivably reach the market as soon as the end of next year. Lilly’s donanemab is similar to Aduhelm but potentially more effective.

Related Posts

The Fed’s Inflation View Is All About That Base

June 6, 2021

June 6, 2021

Federal Reserve officials are talking a lot these days about base effects. That relates to how the economy looks now...

SEC to Review Market Structure as Meme Stocks Stir Frenzy

June 9, 2021

June 9, 2021

The Securities and Exchange Commission is considering changes to some of the stock market’s most fundamental rules in light of...

Why Crime Could Kill Crypto

June 18, 2021

June 18, 2021

The strongest argument against cryptocurrencies used to be that they had yet to show they were much good for anything....

Apple Prepares Office Staff for Hybrid Workweek

June 3, 2021

June 3, 2021

Apple Chief Executive Tim Cook, in an email to staff, notified office employees of the company’s back-to-office plans. Photo: brooks...

Intel Delays New Chip in First Setback for CEO Gelsinger’s Turnaround Effort

June 29, 2021

June 29, 2021

Chip maker Intel Corp. is delaying production of one of its newest chips to improve performance, the first significant product...

Uber, Lyft Sweeten Job Perks Amid Driver Shortage, Lofty Fares

July 2, 2021

July 2, 2021

A shortage of drivers in the U.S. is propelling prices for Uber and Lyft LYFT 0.58% rides to record highs...

John McAfee, Antivirus Software Creator, Is Found Dead in Spanish Jail

June 23, 2021

June 23, 2021

John McAfee, the antivirus software pioneer who founded cybersecurity company McAfee, was found dead Wednesday in a jail cell in...

Hotels’ and Restaurants’ Rebound Summer Held Back by Shortages of Everything

June 25, 2021

June 25, 2021

Shut for long stretches because of the pandemic, Mississippi River Distilling Co. in LeClaire, Iowa, has been counting on a...

Economy Week Ahead: Imports, Jobless Claims, Inflation

June 6, 2021

June 6, 2021

A man moving boxes at a business in New York City, June 4. Photo: Spencer Platt/Getty Images By WSJ staff...

Japanese Business Leaders Add to Chorus Against Holding Olympics

May 24, 2021

May 24, 2021

TOKYO—Opposition to the Tokyo Olympics opening in two months has deepened in Japan and spread to some prominent business leaders...

Robust Spending Is Likely Propelling Economy to Stronger Growth

May 28, 2021

May 28, 2021

Americans likely extended a spending binge in April as they continued catching up on activities they held off on during...

Kantar Hires Chris Jansen as Its New CEO

July 1, 2021

July 1, 2021

Data and media research business Kantar has named Chris Jansen its new chief executive officer, effective Nov. 1. Mr. Jansen,...

Biden’s Capital-Gains Tax Proposal Puts Estate Planners to Work

June 8, 2021

June 8, 2021

Estate planners for the wealthiest Americans are combing through the Biden administration’s proposed tax increases, hunting for ways to sidestep...

As Amazon, McDonald’s Raise Wages, Small Businesses Struggle to Keep Up

May 20, 2021

May 20, 2021

Ben Johnson is looking for a data analyst and a data scientist to come work for his Philadelphia-area consulting firm....

Biden Nears Endgame on Fed Chair Decision

November 22, 2021

November 22, 2021

President Biden faces one of the most important economic policy decisions of his presidency, which is expected this week, when...